These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1142 related articles for article (PubMed ID: 12833452)

  • 1. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
    Chow SM; Yau S; Kwan CK; Poon PC; Law SC
    Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
    Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
    Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary thyroid carcinoma: factors influencing recurrence and survival.
    Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
    Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
    Grigsby PW; Reddy RM; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
    Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
    J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control.
    Sugitani I; Fujimoto Y; Yamamoto N
    Surgery; 2008 Jan; 143(1):35-42. PubMed ID: 18154931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after treatment of papillary thyroid microcarcinoma.
    Appetecchia M; Scarcello G; Pucci E; Procaccini A
    J Exp Clin Cancer Res; 2002 Jun; 21(2):159-64. PubMed ID: 12148571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
    Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
    Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of papillary microcarcinoma of the thyroid gland.
    Orsenigo E; Beretta E; Fiacco E; Scaltrini F; Veronesi P; Invernizzi L; Gini P; Fiorina P; Di Carlo V
    Eur J Surg Oncol; 2004 Dec; 30(10):1104-6. PubMed ID: 15522558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular thyroid carcinoma: prognostic factors and the role of radioiodine.
    Chow SM; Law SC; Mendenhall WM; Au SK; Yau S; Yuen KT; Law CC; Lau WH
    Cancer; 2002 Aug; 95(3):488-98. PubMed ID: 12209740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.